Jay S. Stout, Chief Technology Officer at Immunovant, Inc. (IMVT), sold 3,809 shares at $32.06 ($122K) on 2026-10-07, disclosed to the SEC on 2026-10-09.
Open-market sale of $122k IMVT by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.06 | 1,596 | $51K | 41.9% |
| 2 | $32.06 | 2,213 | $71K | 58.1% |
| Total | $32.06 avg | 3,809 | $122K | 100% |